Patents by Inventor Jill M. SCHARTNER

Jill M. SCHARTNER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FLT3 LIGAND FUSION PROTEINS AND METHODS OF USE
    Publication number: 20230279067
    Abstract: The invention provides an effectorless immunoglobulin Fc protein, fusions of the effectorless Fc protein to a Flt3 ligand, and methods of using the same.
    Type: Application
    Filed: November 21, 2022
    Publication date: September 7, 2023
    Applicant: Genentech, Inc.
    Inventors: Yichin LIU, Christine Carine MOUSSION, Travis William BAINBRIDGE, lraj HOSSEINI, Gregory Alan LAZAR, Sivan COHEN, Christopher Charles KEMBALL, Jill M. SCHARTNER
  • FLT3 ligand fusion proteins and methods of use
    Patent number: 11542308
    Abstract: The invention provides an effectorless immunoglobulin Fc protein, fusions of the effectorless Fc protein to a Flt3 ligand, and methods of using the same.
    Type: Grant
    Filed: May 23, 2022
    Date of Patent: January 3, 2023
    Assignee: Genentech, Inc.
    Inventors: Yichin Liu, Christine Carine Moussion, Travis William Bainbridge, Iraj Hosseini, Gregory Alan Lazar, Sivan Cohen, Christopher Charles Kemball, Jill M. Schartner
  • FLT3 LIGAND FUSION PROTEINS AND METHODS OF USE
    Publication number: 20220289803
    Abstract: The invention provides an effectoriess immunoglobulin Fc protein, fusions of the effectorless Fc protein to a Flt3 ligand, and methods of using the same.
    Type: Application
    Filed: May 23, 2022
    Publication date: September 15, 2022
    Applicant: Genentech, Inc.
    Inventors: Yichin LIU, Christine Carine MOUSSION, Travis William BAINBRIDGE, Iraj HOSSEINI, Gregory Alan LAZAR, Sivan COHEN, Christopher Charles KEMBALL, Jill M. SCHARTNER